Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014

Aug 20, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-08-15

Reporting Person: Petersen Floyd F. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-15	Common Stock	P	3200	$10.3524	Acquired	41612	Direct

Footnotes

F1: This includes 5,457 shares underlying deferred stock units that were granted on 12/20/2013 and fully vest on the first anniversary of the grant date. Such shares were previously reported on a separate line on the Reporting Person's Form 3 filed 6/24/14 but are now consolidated with the Reporting Person's other direct holdings for convenience.